EnBiotix, Mayo Clinic deal

EnBiotix and Mayo Clinic partnered to develop EnBiotix’s EPP-001. The product, an engineered bacteriophage that uses customized phages coding for biofilm-degrading enzyme payloads, is in preclinical ...